Galectin Therapeutics To Hold Conference Call To Provide Corporate Update Following Company's Annual Meeting Of Shareholders

Published: May 08, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ATLANTA, May 8, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics (Nasdaq:GALT) will host a conference call at 9:45 A.M. Eastern Time on Wednesday, May 14, 2014, to provide a corporate update following the Company's Annual Meeting of Shareholders. Additionally, Peter Traber, MD, President, CEO and CMO of Galectin Therapeutics, will update the investment community on the Company's pipeline of galectin inhibitor compounds and progress in development of treatments for liver fibrosis and cancer.

Help employers find you! Check out all the jobs and post your resume.

Back to news